Skip to main navigation

About
Research & Development
Pipeline
Investors
Careers

Press Releases

Press Releases

Year

July 19, 2022

Revolution Medicines Announces Commencement of Public Offering of Common Stock

July 13, 2022

Revolution Medicines Appoints Lorence Kim, M.D., Accomplished Health Care Industry Leader, to Board of Directors

June 28, 2022

Revolution Medicines Advances First RAS(ON) Inhibitor into Clinic, Dosing First Patient in Phase 1/1b Trial of RMC-6236

June 9, 2022

Revolution Medicines to Participate in the 43rd Annual Goldman Sachs Global Healthcare Conference

May 9, 2022

Revolution Medicines Reports First Quarter 2022 Financial Results and Update on Corporate Progress

April 21, 2022

Revolution Medicines to Report Financial Results for First Quarter 2022 After Market Close on May 9, 2022

March 9, 2022

Revolution Medicines Announces Seven Oral Presentations at the Upcoming American Association for Cancer Research Annual Meeting 2022

March 1, 2022

Revolution Medicines to Participate in Cowen 42nd Annual Health Care Conference

February 28, 2022

Revolution Medicines Reports Fourth Quarter and Year-End 2021 Financial Results and Update on Corporate Progress

February 22, 2022

Revolution Medicines to Report Financial Results for Fourth Quarter and Full Year 2021 After Market Close on February 28, 2022

Pagination

First page
Previous page
Page 1
Page 2
Page 3
Current page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Displaying 31 - 40 of 113

Email Alerts

RSS Feeds

Print Page

Contact IR

© 2023 Revolution Medicines, Inc. | 700 Saginaw Drive | Redwood City, CA 94063
CCPA Notice | Privacy Policy

Search Investor Relations